Zymergen– Making discoveries far beyond the capacity of human intuition

In today's highly competitive scenario, a streamlined, standardized infrastructure is integral to the way applications, business processes, and services are delivered. But many companies have also realized that this vital aspect of their business is a significant contributor to the costs of operations. It's not surprising, therefore, that technology in infrastructure is not considered a luxury but rather a necessity as it helps achieve significant cost reductions. Technology in support is not limited to just information technology, though. It encompasses a wide variety of other disciplines ranging from mechanical to architectural.

Because of new computing technologies, machine learning today is not like machine learning of the past. It was born from pattern recognition and the theory that computers can learn without being programmed to perform specific tasks; researchers interested in artificial intelligence wanted to see if computers could learn from data. The iterative aspect of machine learning is essential because, as models are exposed to new data, they can independently adapt. They learn from previous computations to produce reliable, repeatable decisions and results. It's a science that's not new – but one that has gained fresh momentum.

A lot has been happening in the science of genomics over the past few years. It is, for example, now possible to read one human genome and correct all known errors. Perhaps this sounds terrifying, but genomic science has a track-record in making science fiction reality. By 2020, many hospitals will have genomic medicine departments, designing medical therapies based on your genetic constitution. By 2025, projections suggest that we will have sequenced the genomes of billions of individuals.

One such firm which is a pioneer in machine learning, genomics, and automation services is Zymergen.

Zymergen integrates automation, machine learning, and genomics to accelerate the pace of scientific advancement rapidly. The firm treats the genome as a search space, leveraging machine learning to make discoveries far beyond the bounds of human intuition. The platform integrates automation, machine learning, and genomics to accelerate the pace of scientific advancement rapidly. This approach leverages machine learning to navigate the genomic search space to make discoveries far beyond the capacity of human intuition.

Zymergen uses biology as a source of new chemical building blocks that enable the development of novel products and materials. Importantly, they work at scale –– improving industrial economics while making new markets realizable.

Zymergen technologies and solutions

Developing New Products

The firm produces novel specialty chemicals or brings you valuable natural products to serve your business needs.

Accelerating Commercialization

Zymergen can take your product from concept to commercialization faster.

Improving Sustainability

The company reduces your footprint with its bio-based approach.

Optimizing Economics

The company improves the economics of your mature, in-market products.

Core Platform

The company has a uniquely flexible platform and data infrastructure that can accommodate a range of microbes and genetic information.

Genetic Libraries

With more than two terabases of proprietary physical and digital DNA data, Zymergen's is the most extensive catalog of gene diversity in the world.

Material Innovation

The firm tapped into wholly new chemical building blocks from biology to deliver unique material properties, not previously possible.

The ultimate leader behind the victory of Zymergen

Joshua Hoffman serves as the Chief Executive Officer of Zymergen. Before Zymergen, Mr. Joshua was a Partner at Norcob Capital, and before that, a Managing Director in Merchant Banking at Rothschild, he was a Management Committee member. He began his career at McKinsey & Company, where he served industrial and technology clients on matters of strategy, operations, and organization. He holds a BA from the University of California, Berkeley, and an MA and MPPM from Yale University.

“Zymergen is not just changing the way stuff is made; we're changing stuff itself.”